United States · FDA National Drug Code directory
mirtazapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72865-371_575adbdd-e91b-3054-e063-6294a90ad7c0
- Product NDC
- 72865-371
- Form
- TABLET, FILM COATED
- Composition / generic term
- mirtazapine
- Labeler
- XLCare Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251002
- Source listing expiry
- 20271231
Source-listed ingredients
- MIRTAZAPINE — 45 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED in 1 BOTTLE (72865-371-05) · 72865-371-05
- 30 TABLET, FILM COATED in 1 BOTTLE (72865-371-30) · 72865-371-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →